Blockade of the specific lethal effects of narcotic analgesics in the mouse.
The capacity of the narcotic antagonists naloxone and nalorphine and the benzodiazepine derivatives diazepam and oxazepam to increase the LD50s of the narcotic analgesics morphine and methadone administered at convulsant doses was eveluated in the mouse. Naloxone produced a dose-related increase in the LD50s of both morphine and methadone. Iiazepam and oxazepam were also effective in increasing the LD50s of the narcotics; this effect was additive with that of naloxone. However, the maximal increase in the LD50s of the narcotics produced by pretreatment with naloxone alone was not increased further by the combined pretreatment of naloxone and a benzodiazepine. The anticonvulsant trimethadione did not elevate the LD50s of methadone, nor did it potentiate the effects of naloxone. These results suggest that the benzodiazepines may reduce the lethality of narcotic analgesics administered at high doses by a mechanism other than by an anticonvulsant effect alone. Therefore, the present results support the conclusion that the capacity to increase the convulsant LD50 of the narcotic analgesics is a general property of the narcotic antagonists.
D000818:Animals; D001569:Benzodiazepines / Q000494:pharmacology*; D003975:Diazepam / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D007928:Lethal Dose 50; D008297:Male; D008691:Methadone / Q000037:antagonists & inhibitors*; D051379:Mice; D009020:Morphine / Q000037:antagonists & inhibitors*; D009269:Nalorphine / Q000494:pharmacology; D009270:Naloxone / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000494:pharmacology*; D010076:Oxazepam / Q000494:pharmacology; D014293:Trimethadione / Q000494:pharmacology
D009292:Narcotic Antagonists; D001569:Benzodiazepines; D009270:Naloxone; D010076:Oxazepam; D009020:Morphine; D003975:Diazepam; D014293:Trimethadione; D009269:Nalorphine; D008691:Methadone